Feed Items
- previous post: Pyronaridine–artesunate or dihydroartemisinin–piperaquine vs current first-line therapies for repeated treatment of uncomplicated malaria: A randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
- next post: Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium
